SINTX Technologies
NASDAQ: SINTA silicon nitride ceramics company for spinal and orthopaedic implants. Its 3D printing work is a silicon nitride and PEEK composite for patient-specific spinal implants, funded in part by NIH grants.
- Status
- Listed
- Listing
- NASDAQ: SINT
- Headquarters
- Salt Lake City, Utah, United States
- Ownership
- Listed on Nasdaq (SINT)
- Technologies
- silicon nitride, silicon nitride-PEEK, patient-specific implants
Live chart and quote by TradingView. Data may be delayed.
Timeline
- 2021Sep 2021
Receives a first NIH grant of 308,301 dollars for a 3D printed silicon nitride-PEEK spinal implant
- 2023Oct 2023
Awarded a 1,972,826 dollar Phase II NIH grant for 3D printed silicon nitride-PEEK composite spinal implants
- 2025Dec 2025
Signs a supply agreement with Evonik to make the silicon nitride-PEEK compound at commercial scale for AI-assisted printing of patient-specific implants
- 2026Aug 2026
Finishes building a 3D printing facility for its SiNERGY patient-specific silicon nitride-PEEK implants and gets a 12-month NIH extension
About 745,000 dollars remained on the 1.97 million dollar grant.
Last checked . Informational only, not investment advice. Timeline entries are compiled by hand from public sources and can lag real events. Figures come from company reports and news, not from us. Private companies rarely publish financials; where a figure is not disclosed we say so instead of estimating it. This page as JSON, free to use with a credit: open data.